US Map / Colorado
State CO

Clinical Trials in Colorado

Recruiting clinical trials with at least one study location in Colorado. Data updated daily from ClinicalTrials.gov.

Total Trials
264
Recruiting Now
264
← Back to US Map
Top Conditions in Colorado
Breast Cancer (6)Colorectal Cancer (6)Multiple Myeloma (5)Chronic Lymphocytic Leukemia (5)Advanced Solid Tumors (4)Depression (4)Small Lymphocytic Lymphoma (4)Non-small Cell Lung Cancer (3)Spinal Cord Injuries (3)Rheumatoid Arthritis (3)Asthma (3)Neuroblastoma (3)

Frequently Asked Questions — Clinical Trials in Colorado

How many clinical trials are currently recruiting in Colorado?
ClinicalMetric currently tracks 264 actively recruiting clinical trials with at least one location in Colorado. The total number of registered studies—including active but not currently enrolling trials—is 264. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Colorado?
Colorado hosts clinical trials across a broad range of medical conditions, including Breast Cancer, Colorectal Cancer, Multiple Myeloma, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Colorado serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Colorado?
To join a clinical trial in Colorado, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Colorado maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Colorado

NCT05169515 Phase 1
Recruiting
A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Mosunetuzumab o...
Condition
Non-Hodgkin Lymphoma
Enrollment
121 pts
Location
United States, Israel, Italy
Sponsor
Hoffmann-La Roche
View Trial →
NCT05775718 Phase 2
Recruiting
Shingrix In Recipients of Allogeneic Transplants
Condition
Bone Marrow Transplant
Enrollment
55 pts
Location
United States
Sponsor
University of Colorado, Denver
View Trial →
NCT04655404 EARLY_Phase 1
Recruiting
A Pilot Study of Larotrectinib for Newly-Diagnosed High-Grade Glioma With NTRK F...
Condition
High Grade Glioma
Enrollment
15 pts
Location
United States, Australia, Canada
Sponsor
Nationwide Children's Hospital
View Trial →
NCT06535789 Phase 2, Phase 3
Recruiting
Inhaled Insulin vs Rapid-acting Injections for Post-meal Glucose Control in Wome...
Condition
Diabetes, Gestational
Enrollment
30 pts
Location
United States
Sponsor
Jaeb Center for Health Researc
View Trial →
NCT05828069 Phase 2
Recruiting
A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapse...
Condition
Recurrent Langerhans Cell Histiocytosis
Enrollment
48 pts
Location
United States, Australia, Canada
Sponsor
National Cancer Institute (NCI
View Trial →
NCT06967805 Phase 2
Recruiting
WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis...
Condition
Idiopathic Pulmonary Fibrosis
Enrollment
164 pts
Location
United States, Argentina, Australia
Sponsor
Mediar Therapeutics
View Trial →
NCT05533697 Phase 1, Phase 2
Recruiting
Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint ...
Condition
Advanced Solid Tumors
Enrollment
361 pts
Location
United States, Australia, Spain
Sponsor
ModernaTX, Inc.
View Trial →
NCT04678154 Phase 3
Recruiting
Evaluation of a New Strategy for Protocolized Antibiotic Care for Severe Open Fr...
Condition
Post Operative Surgical Site Infection
Enrollment
1,200 pts
Location
United States
Sponsor
Major Extremity Trauma Researc
View Trial →
NCT06376162 Phase 1
Recruiting
Ziftomenib in Combination With Chemotherapy for Children With Relapsed/Refractor...
Condition
Relapsed/Refractory KMT2A-r Acute Leukemia
Enrollment
20 pts
Location
United States, Austria, Canada
Sponsor
PedAL BCU, LLC
View Trial →
NCT06016946 N/A
Recruiting
Friedreich Ataxia Global Clinical Consortium UNIFIED Natural History Study
Condition
Friedreich Ataxia
Enrollment
3,000 pts
Location
United States, Australia, Austria
Sponsor
Friedreich's Ataxia Research A
View Trial →
NCT05732623 N/A
Recruiting
Exogenous and Endogenous Risk Factors for Early-onset Colorectal Cancer
Condition
Colorectal Cancer
Enrollment
2,300 pts
Location
United States, Finland, Germany
Sponsor
San Raffaele University
View Trial →
NCT06165341 Phase 3
Recruiting
Study to Learn About the Safety of Fazirsiran and if it Can Help People With Alp...
Condition
Alpha1-Antitrypsin Deficiency
Enrollment
50 pts
Location
United States, Austria, Belgium
Sponsor
Takeda
View Trial →
NCT07015905 Phase 3
Recruiting
REGN7508 Versus Apixaban and Enoxaparin for Thromboprophylaxis After Total Knee ...
Condition
Venous Thromboembolism (VTE)
Enrollment
2,000 pts
Location
United States, Bulgaria, Hungary
Sponsor
Regeneron Pharmaceuticals
View Trial →
NCT06944522 Phase 3
Recruiting
A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Ha...
Condition
Parkinsons Disease (PD)
Enrollment
102 pts
Location
United States, Australia, Canada
Sponsor
BlueRock Therapeutics
View Trial →
NCT06587113 N/A
Recruiting
An Investigation of Attentional and Inhibitory Processes During Active Visual Se...
Condition
Eye Movements
Enrollment
225 pts
Location
United States
Sponsor
University of Colorado, Denver
View Trial →
NCT05238922 Phase 1
Recruiting
Study of INCB123667 in Subjects With Advanced Solid Tumors
Condition
Solid Tumors
Enrollment
604 pts
Location
United States, France, Italy
Sponsor
Incyte Corporation
View Trial →
NCT02997345 N/A
Recruiting
PPROM Registry (Preterm Premature Rupture of Membranes)
Condition
Fetal Membranes, Premature Rupture
Enrollment
3,000 pts
Location
United States
Sponsor
American Alliance for pProm Su
View Trial →
NCT06976203 Phase 3
Recruiting
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Imp...
Condition
Alzheimer's Disease
Enrollment
586 pts
Location
United States, Argentina, Australia
Sponsor
Bristol-Myers Squibb
View Trial →
NCT02852031 N/A
Recruiting
National Collaborative to Improve Care of Children With Complex Congenital Heart...
Condition
Hypoplastic Left Heart Syndrome (HLHS)
Enrollment
1,000 pts
Location
United States, Canada, United Kingdom
Sponsor
Children's Hospital Medical Ce
View Trial →
NCT06375083 Phase 2
Recruiting
Computerized Cognitive Behavioral Therapies for Suicide Prevention and Depressio...
Condition
Suicide
Enrollment
472 pts
Location
United States
Sponsor
VA Eastern Colorado Health Car
View Trial →
NCT05288803 N/A
Recruiting
Improving Rehabilitation for Veterans After Total Knee Arthroplasty Using Indivi...
Condition
Total Knee Arthroplasty
Enrollment
200 pts
Location
United States
Sponsor
VA Office of Research and Deve
View Trial →
NCT06020261 N/A
Recruiting
Parent Management Training to Treat Irritability
Condition
Irritable Mood
Enrollment
36 pts
Location
United States
Sponsor
University of Colorado, Denver
View Trial →
NCT07052942 Phase 4
Recruiting
Individualizing Treatment for Asthma in Primary Care (Full Study)
Condition
Asthma
Enrollment
3,200 pts
Location
United States
Sponsor
DARTNet Institute
View Trial →
NCT06395103 Phase 1, Phase 2
Recruiting
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants Wit...
Condition
B-cell Acute Lymphoblastic Leukemia
Enrollment
90 pts
Location
United States, Australia, Belgium
Sponsor
Merck Sharp & Dohme LLC
View Trial →
NCT06894979 Phase 1
Recruiting
Testing the Addition of an Anti-Cancer Drug, AZD1390, During Radiation Therapy f...
Condition
Childhood Astrocytoma
Enrollment
54 pts
Location
United States
Sponsor
Children's Oncology Group
View Trial →
Page 2 of 11 — 264 trials total
← Prev Next →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology